Next Article in Journal
Characterization of the GBoV1 Capsid and Its Antibody Interactions
Next Article in Special Issue
Pharmacogenetics Approach for the Improvement of COVID-19 Treatment
Previous Article in Journal
Standard Bacteriophage Purification Procedures Cause Loss in Numbers and Activity
Previous Article in Special Issue
Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 13
Issue 2
10.3390/v13020329
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea

by
Seongman Bae
1,†,
Byeongzu Ghang
2,†,
Ye-Jee Kim
3,
Joon Seo Lim
4,
Sung-Cheol Yun
3,
Yong-Gil Kim
5,
Sang-Oh Lee
1 and
Sung-Han Kim
1,*
1
Asan Medical Center, Department of Infectious Diseases, University of Ulsan College of Medicine, Seoul 05505, Korea
2
Division of Rheumatology, Department of Internal Medicine, Jeju National University School of Medicine, Jeju National University Hospital, Jeju 63241, Korea
3
Asan Medical Center, Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Seoul 05505, Korea
4
Clinical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul 05505, Korea
5
Asan Medical Center, Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul 05505, Korea
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Viruses 2021, 13(2), 329; https://doi.org/10.3390/v13020329
Submission received: 26 January 2021 / Revised: 15 February 2021 / Accepted: 15 February 2021 / Published: 20 February 2021
(This article belongs to the Special Issue Vaccines and Therapeutics against Coronaviruses)
Browse Figure
Versions Notes

Abstract

Background: To evaluate the role of hydroxychloroquine (HCQ) as pre-exposure prophylaxis against coronavirus disease 2019 (COVID-19), we investigated the prevalence of positive test results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing according to recent HCQ use in patients who had been tested using nationwide health-insurance data of South Korea. Methods: All adults tested for SARS-CoV-2 from 20 January 2020 to 15 May 2020 were identified. HCQ users were defined as patients who had been pretreated with HCQ for at least 30 days until the date of SARS-CoV-2 testing. The prevalence of positive PCR results for SARS-CoV-2 was compared between HCQ users and nonusers. Results: Of a total of 216,686 individuals who had been tested for SARS-CoV-2, 743 (0.3%) were pretreated with HCQ. The prevalence of positive results was not significantly different between HCQ users (2.2%) and nonusers (2.7%; P = 0.35), with an odds ratio of 0.79 (95% confidence interval (CI), 0.48–1.30). Propensity score-matched-cohort analysis showed similar results in terms of the prevalence of positive results (2.2% in HCQ users vs. 3.1% in nonusers; P = 0.18), with an odds ratio of 0.69 (95% CI, 0.40–1.19). The rate of positive PCR was not significantly different in long-term HCQ users (more than 3 or 6 months) compared with nonusers. Conclusions: In this population-based study, recent exposure to HCQ was not significantly associated with a lower risk of SARS-CoV-2 infection. Our data do not support the use of HCQ as pre-exposure prophylaxis against COVID-19.
Keywords: hydroxychloroquine; SARS-CoV-2; COVID-19; prophylaxis hydroxychloroquine; SARS-CoV-2; COVID-19; prophylaxis

Share and Cite

MDPI and ACS Style

Bae, S.; Ghang, B.; Kim, Y.-J.; Lim, J.S.; Yun, S.-C.; Kim, Y.-G.; Lee, S.-O.; Kim, S.-H. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea. Viruses 2021, 13, 329. https://doi.org/10.3390/v13020329

AMA Style

Bae S, Ghang B, Kim Y-J, Lim JS, Yun S-C, Kim Y-G, Lee S-O, Kim S-H. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea. Viruses. 2021; 13(2):329. https://doi.org/10.3390/v13020329

Chicago/Turabian Style

Bae, Seongman, Byeongzu Ghang, Ye-Jee Kim, Joon Seo Lim, Sung-Cheol Yun, Yong-Gil Kim, Sang-Oh Lee, and Sung-Han Kim. 2021. "Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea" Viruses 13, no. 2: 329. https://doi.org/10.3390/v13020329

APA Style

Bae, S., Ghang, B., Kim, Y.-J., Lim, J. S., Yun, S.-C., Kim, Y.-G., Lee, S.-O., & Kim, S.-H. (2021). Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea. Viruses, 13(2), 329. https://doi.org/10.3390/v13020329

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop